21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER
#10202COMPOSITIONS AND METHODS FOR TREATMENT OF INFECTION AND NOVEL COSMECEUTICAL PREPARATIONS
#10203NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU
#10204ORGANIC COMPOUNDS
#10205Pemafibrate dosing regimens
#10206COMPOSITIONS AND METHODS FOR TREATMENT OF OVARIAN AND BREAST CANCER
#10207METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME
#10208USE OF AMISULPRIDE AS AN ANTI-EMETIC
#10209Oral dissolvable film that includes plant extract
#10210Nutraceutical compositions
#10211COMBINATIONS OF BCL-2/BCL-XL INHIBITORS AND RELATED USES
#10212PREVENTATIVE OR THERAPEUTIC AGENT FOR TAUOPATHY
#10213METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES
#10214Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
#10215METHODS AND COMPOSITIONS FOR PREVENTING SKIN TOXICITIES CAUSED BY BIOLOGICAL TARGETED CANCER DRUGS
#10216NOVEL PHARMACEUTICAL COMPOSITIONS
#10217PRE-FILLING SYSTEM TO ELIMINATE BUBBLES INSIDE CAPSULES HAVING A SOLID DOSAGE FORMS WITHIN SAID CAPSULES
#10218Pharmaceutical compositions of berberine with EPA and DHA, and methods thereof
#10219Method and System for Preventing Sore Throat in Humans
#10220PREDICTING EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE
#10221GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF USES THEREOF
#10222miRNAS FOR REDUCING VENTRICLE ENLARGEMENT
#10223PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS INJECTION COMPRISING HUMAN HYALURONIDASE PH20 VARIANT AND DRUG
#10224Immunomodulatory antibodies and methods of use thereof
#10225Cystic Fibrosis Transmembrane Conductance Regulator Stabilizing Agents
#10226Anti-PACAP antibodies and uses thereof
#10227SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL-23 SPECIFIC ANTIBODY
#10228Use of beta-catenin as a biomarker for treating cancers using anti-Dkk-1 antibody
#10229ANTI-HIV VACCINE ANTIBODIES WITH REDUCED POLYREACTIVITY
#10230HUMAN MONOCLONAL ANTIBODIES TO ENTEROVIRUS D68
#10231NEUTRALIZING ANTIBODIES TO SARS-COV-2 AND ITS VARIANTS
#10232USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION
#10233NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#10234ENPP1 Inhibitors and Methods of Modulating Immune Response
#10235NLRP3 modulators
#102363,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS
#10237(R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASES
#10238Compounds for the treatment of BRAF-associated diseases and disorders
#10239COMPOSITIONS OF NRF2 INHIBITING AGENTS AND METHODS OF USE THEREOF
#10240Metabolism resistant fenfluramine analogs and methods of using the same
#10241System and methods for treating cancer cells with alternating polarity magnetic fields
#10242System and methods for treating cancer cells with alternating polarity magnetic fields
#10243METHODS FOR APPLYING TUMOR TREATING FIELDS IN COMBINATION WITH CANCER TREATING THERAPEUTICS
#10244Methods of Treating Disease by Skewing Macrophage Phenotype with Alternating Electric Fields
#10245Medical devices for continuous delivery of therapeutic agents
#10246Ultrasound Responsive Microbubbles And Related Methods
#10247DOSAGE-INDICATING TOPICAL FORMULATION AND METHOD OF USING A DOSAGE-INDICATING TOPICAL FORMULATION
#10248Photosensitizing antibody-fluorophore conjugates
#10249HOMEOPATHIC COMPLEX
#10250DOSAGE AND ADMINISTRATION OF ANTI-ERBB3 (HER3) MONOCLONAL ANTIBODIES TO TREAT TUMORS ASSOCIATED WITH NEUREGULIN 1 (NRG1) GENE FUSIONS
#10251INFLUENZA HEMAGGLUTININ PROTEINS AND METHODS OF USE THEREOF
#10252MICROVASCULAR BLOOD FLOW DECREASING AGENT AND USE THEREOF
#10253CYTOKINE MODULATION
#10254NOVEL ENTERIC COMBINATION THERAPY
#10255PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING VACCINIA VIRUS AND GRANULOPOIESIS INHIBITOR AS ACTIVE INGREDIENTS
#10256GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS
#10257Alkalized organic pharmaceutical or nutraceutical composition
#10258DEPLETION REGIMES FOR ENGINEERED T-CELL OR NK-CELL THERAPY
#10259Compounds for Hepatitis B Treatment
#10260Synergistic formulations of adenosine receptor modulating agents and anticholinergics
#10261Method for Improving Insulin Sensitivity
#10262TREATMENT FOR BACTERIAL INFECTION
#10263D9-caffeine compositions and uses thereof
#10264Method against severe acute respiratory syndrome coronavirus 2 infection
#10265Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
#10266PROSTATITIS TREATMENT
#10267Compounds for the treatment of BRAF-associated diseases and disorders
#10268Optically active azabicyclo ring derivative
#10269INHIBITORS OF TYROSINE KINASE
#10270PHARMACEUTICAL PREPARATION
#10271MONOCYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING
#10272TREATMENT OF T-CELL MEDIATED DISEASES
#10273Treatment of Opioid Withdrawal
#10274CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF PREPARATION THEREOF
#10275COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
#10276METHODS FOR TREATING CANCER USING SERIAL ADMINISTRATION OF E3 UBIQUITIN LIGASE DEGRADERS
#10277METHOD FOR TREATING A DISEASE OR CONDITION USING A PYRAZOLE COMPOUND OR FORMULATION THEREOF
#10278SMALL MOLECULE INHIBITOR OF THE JAK FAMILY OF KINASES
#10279USE OF PYRVINIUM FOR THE TREATMENT OF A RAS PATHWAY MUTATED ACUTE MYELOID LEUKEMIA
#10280METHOD OF REDUCING ABERRANT IMMUNE RESPONSE OR RISK OF PROGRESSION IN COVID-19
#10281GLP-1R modulating compounds
#10282A THERAPEUTIC APPROACH FOR TREATING NON-INFECTIOUS OCULAR IMMUNOINFLAMMATORY DISORDERS
#10283Methods of improving renal function
#10284METHODS OF TREATING KIDNEY DISEASES
#10285Methods of treating cancer using a combination of SERD Dosing Regimens
#10286METHODS AND COMPOSITIONS FOR THE TREATMENT OF PRE-DIABETES, DIABETES AND METABOLIC SYNDROME
#10287CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF
#10288Pharmaceutical composition, methods for treating and uses thereof
#10289METHODS FOR REDUCING REWARDING EFFECTS OF MORPHINE WITHOUT AFFECTING ITS ANALGESIC EFFECTS
#10290COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY
#10291N,N-bis-2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseases
#10292Intraarterial (IA) Application of Low Dose of Ethyl Alcohol Enables Blood-Brain Barrier (BBB) Impermeable Therapeutics Brain Entry
#10293PHARMACEUTICAL COMPOSITION AND USES THEREOF
#10294ORAL PRODUCTS AND METHODS OF MANUFACTURE
#10295OLEOGELS AND METHODS RELATING THERETO
#10296Devices and methods for treating ear pain
#10297HYDROGEL BASED ON ZINC GLUCONATE AND HYALURONIC ACID ESTERS
#10298SKIN SERUM AND PROCESS OF MAKING THE SAME
#10299P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD
#10300Primary NK CAR Constructs And Methods
#10301Method and Compositions for Inducing Differentiation of Myeloid Derived Suppressor Cell to Treat Cancer and Infectious Diseases
#10302Anti-PD-1 antibodies for treatment of lung cancer
#10303Pharmaceutical Combinations
#10304Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies
#10305COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH
#10306Method for the treatment of a relapsing-remitting condition
#10307pH-SENSITIVE CYCLIC PEPTIDES
#10308Immunotherapy against several tumors including lung cancer
#10309TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF
#10310NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES
#103111H-[1, 2, 3]triazolo[4, 5-h] quinazoline compounds acting as protein kinase inhibitors
#10312Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK Inhibitors
#10313COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS
#10314Prodrug Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#10315COMBINATION THERAPY FOR TREATING CANCER
#10316Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands
#10317AURORA KINASE AND JANUS KINASE INHIBITORS FOR PREVENTION OF GRAFT VERSUS HOST DISEASE
#10318HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
#10319CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS
#10320CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#10321METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY
#10322FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#10323VACCINE COMPOSITIONS COMPRISING C-C MOTIF CHEMOKINE 22 (CCL22) OR FRAGMENTS THEREOF
#10324COMBINATION CANCER THERAPY AGENTS AND METHODS
#10325Treatment of Heart Defects and Conditions in Pediatric Patients
#10326METHOD OF PREPARING A DE-FIBRINATED PLATELET LYSATE, AND USES OF SAID METHOD
#10327METHOD FOR TREATMENT OF HEPATIC CANCER USING REIC/Dkk-3 GENE IN COMBINATION WITH ANTI-TUMOR AGENT
#10328Collagen peptide-based medicament compositions and devices and methods of production and use thereof
#10329Engineered immunostimulatory bacterial strains and uses thereof
#10330HUMAN UMBILICAL CORD-DERIVED COMPOSITIONS AND USES THEREOF FOR TREATING NEUROPATHY
#10331PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
#10332PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
#10333AGENT FOR THE TREATMENT OF PSORIASIS
#10334RAC INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR EGFR/HER2 TARGETED THERAPY RESISTANT BREAST CANCER
#10335COMBINATION OF PI3K INHIBITOR AND C-MET INHIBITOR
#10336COMBINATIONS OF AGENTS TO TREAT HEMATOLOGICAL MALIGNANCIES
#10337CDK4/6 INHIBITORS FOR THE TREATMENT OF PSORIASIS
#10338AZA-QUINOLINE COMPOUNDS AND USES THEREOF
#10339Dizocilpine derivatives as peripheral NMDA receptor antagonists
#10340COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS
#10341Hodgkin lymphoma therapy
#10342SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES
#10343Compositions And Methods For Treating Traumatic Brain Injury
#10344Methods and compositions for treating infection and inflammation with selenocyanate
#10345Memory in subjects with mini-mental state examination of 24-26
#10346METHODS AND COMPOSITIONS FOR TREATING SMITH-MAGENIS SYNDROME
#10347TREATMENT OF COPPER DISORDER
#10348PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED RESPIRATORY INFECTIONS
#10349RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS
#10350Treprostinil derivatives and their use in pharmaceutical compositions
#10351Tunable leukocyte-based biomimetic nanoparticles and methods of use
#10352TUNABLE LEUKOCYTE-BASED BIOMIMETIC NANOPARTICLES AND METHODS OF USE
#10353DEVICES, METHODS, AND COMPOSITIONS FOR THERMAL ACCELERATION AND DRUG DELIVERY
#10354Stable compositions of uncomplexed iodine and methods of use
#10355Application of raman spectroscopy for the manufacture of inhalation powders
#10356Adeno-associated virus virions for treatment of epilepsy
#10357USE OF RAB7 GTPASE (RAB7) INHIBITORS IN ENHANCING PERMEABILITY OF THE BLOOD BRAIN BARRIER (BBB)
#10358NEW TREATMENTS INVOLVING MIRNA-193A
#10359ANTI-CD38 ANTIBODIES AND METHODS OF USE
#10360Use of Approved Anti-CD38 Antibody Drug Product to Treat Light Chain Amyloidosis
#10361Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases
#10362Antifibrotic activity of CD47 blockade in the liver
#10363ANTIBODIES THAT BIND TO PATHOLOGICAL TAU SPECIES AND USES THEREOF
#10364ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF
#10365RELAXIN ANALOGS AND METHODS OF USING THE SAME
#10366FCRN ANTAGONISTS AND METHODS OF USE
#10367HSP Fusion Protein with Anti-Chemorepellant Agent for Treatment of Cancer
#10368Minimal saponin analogues, synthesis and use thereof
#10369Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
#10370SMALL MOLECULE INHIBITORS OF KU70/80 AND USES THEREOF
#10371PYRAZINO [1,2-B]QUINAZOLINE-3,6-DIONES DERIVATIVES, THEIR PRODUCTION AND USES THEREOF
#10372NOVEL INHIBITORS
#10373Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
#10374CLASS OF TRIAROMATIC COMPOUNDS TARGETING BIFUNCTIONAL PHOSPHORYLATION SITE OF STAT3 AND APPLICATIONS THEREOF
#103755-BROMO-INDIRUBINS
#10376Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof
#10377Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
#10378METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA
#10379SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN
#10380Immunoregulatory agents
#10381Method of treating ocular disorders with compounds found in Harderian gland secretions
#10382ENHANCED TRANSDUCTION OF AAV VECTORS ENCODING MICRORNAS
#10383Cannabinoid Conjugate Molecules
#10384COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION
#10385Vaginal hydrogel
#10386Drug delivery composition, method forming the same and method for treating inner ear disorders
#10387Homeopathic complex
#10388SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER
#10389A TEIXOBACTIN ANALOGUE AND USE THEREOF
#10390Peptidomimetics for the treatment of coronavirus and picorna virus infections
#10391COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF ATOPIC DERMATITIS DISEASE
#10392COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF RESPIRATORY DISEASE
#10393METHODS OF DETECTING OVARIAN CANCER
#10394NUTRITIVE COMPOSITIONS WITH BIOACTIVE PROTEINS
#10395COMPOSITIONS AND METHODS OF TREATMENT OF CHRONIC INFECTIOUS DISEASES
#10396NRF2 ACTIVATION FOR TREATMENT OF NEPHROGENIC DIABETES INSIPIDUS
#10397Altering microbial populations and modifying microbiota
#10398COMPOSITIONS AND METHODS FOR DECREASING INTRAOCULAR PRESSURE
#10399Treatment of Glycosylation Deficiency Diseases
#10400BORON-CONTAINING SMALL MOLECULES
#10401TOPICAL FORMULATIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES
#10402PI3K INHIBITOR FOR USE IN THE THERAPY OF B CELL LYMPHOMA
#10403Compounds for use in a method of treating or preventing neurological and/or psychiatric disorders
#10404NOVEL PFAR-INHIBITING COMPOUNDS
#10405Compounds for use in treating depression and migraine
#10406EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND OF LSD ANALOGS TO ASSIST PSYCHOTHERAPY FOR GENERALIZED ANXIETY DISORDER OR OTHER ANXIETY NOT RELATED TO LIFE-THREATENING ILLNESS
#10407Therapeutic use of levorotatory β-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels
#10408Composition containing artesunate
#10409ANTIMYCOTIC
#10410METHODS OF USING MODIFIED CYTOTOXINS TO TREAT CANCER
#10411COMPOSITIONS AND METHODS FOR STIMULATING VENTILATORY AND/OR RESPIRATORY DRIVE
#10412LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF
#10413COMPOSITIONS AND METHODS FOR TREATING ECZEMA
#10414ANALGESIC FORMULATION FOR PERINEAL PAIN
#10415Diagnosis and Treatment of Vitiligo
#10416MONOAMINE OXIDASE B INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF PROSTATE CARCINOMA
#10417ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS
#10418Composition comprising at least one natural or synthetic non-euphoric cannabinoid and its method of manufacture
#10419Film Formulation Comprising Carriers
#10420CONTINUOUS METHOD FOR NANO-EMULSIFICATION BY CONCENTRATION PHASE INVERSION
#10421Treatment of hip pain with sustained-release liposomal anesthetic compositions
#10422Vaccine adjuvant formulation
#10423High-Throughput Identification of Patient-Specific Neoepitopes as Therapeutic Targets for Cancer Immunotherapies
#10424TREATMENT OF KIDNEY DISEASES ASSOCIATED WITH ELEVATED AVP
#10425THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
#10426ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS
#10427Modified AAV Capsid Proteins for Treatment of Arthritic Disease
#10428CANCER TREATMENT USING TARGETED siRNA PHARMACEUTICAL FORMULATIONS TO DOWNREGULATE EXPRESSION OF PRDM14 PROTEIN
#10429IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME
#10430Human Anti-SOD1 Antibodies
#10431ANTI-IL1RAP ANTIBODIES AND ANTIBODY DRUG CONJUGATES
#10432METHODS AND COMPOSITIONS FOR TARGETING TGF-ß SIGNALING IN CD4+ HELPER T CELLS FOR CANCER IMMUNOTHERAPY
#10433Compositions and methods for treatment of diseases involving CXCL1 function
#10434Use of TGF-alpha polypeptide or anti-TGF-alpha antibodies for the treatment of diseases and disorders
#10435ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF
#10436LONG-LASTING GLP1 ANALOGUE DRUG FOR TYPE-2 DIABETES
#10437MPS MODIFIED PEPTIDES AND USE THEREOF
#10438COMPOSITIONS COMPRISING CHEMERIN ANALOGS AND METHODS OF USE
#10439P53 ACTIVATOR PEPTIDOMIMETIC MACROCYCLES
#10440SUBSTITUTED FUSED HETEROAROMATIC BICYCLIC COMPOUNDS AS KINASE INHIBITORS AND THE USE THEREOF
#10441Dihydro-Spiro[Indoline-3:1'-Isoquinolin]-2-Ones and Their Analogues and Derivatives and Methods of Treating Cancer and Other Diseases
#104424-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES
#10443Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#10444DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES
#104452-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof
#10446HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE
#10447NLRP MODULATORS
#10448Inhibitors of influenza viral entry
#10449TARGETING PTPN22 IN CANCER THERAPY
#10450NEW TRICYCLIC 5-HT2 ANTAGONISTS
#10451ANTIMICROBIAL NANO-DELIVERANT AND METHODS
#10452Drug delivery vehicle, drug delivery system and methods thereof
#10453METHODS AND COMPOSITIONS FOR TREATING NON-SMALL CELL LUNG CANCER
#10454LONG-ACTING FORMULATIONS AND VEHICLES
#10455COMPOSITION AND METHODS OF TARGETING THE PRE-B CELL RECEPTOR FOR THE TREATMENT OF LEUKEMIAS AND LYMPHOMAS
#10456COMBINATION
#10457Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers
#10458Composition for treatment of topical dermatological bacterial skin conditions
#10459Compositions, Methods, and Medical Compositions for Treatment of and Maintaining the Health of the Liver
#10460USE OF VETO CELLS FOR THE TREATMENT OF SICKLE CELL DISEASE
#10461METHODS FOR STEM CELL TRANSPLANTATION
#10462IMMUNOTHERAPIES
#10463IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS
#10464ANTIBODY PRE-LOADED CD16+NK-92 CELLS AS AN EFFECTIVE THERAPEUTIC PRODUCT FOR TUMOR LYSIS
#10465Substituted phenyl boronic acid containing polymers and methods of use
#10466COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#10467METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
#10468Abiraterone prodrugs
#10469Compositions and methods for preventing or treating muscle conditions
#10470Parenteral compositions comprising methylene blue
#10471Triazine formulations with a second active ingredient and surfactant(s)
#10472Composition for treatment of muscular disorders
#10473COMBINATION THERAPIES WITH IRE1 SMALL MOLECULE INHIBITORS
#10474METHODS OF TREATING INFLAMMATORY DISEASES
#10475DOSAGE REGIMENS FOR PARP7 INHIBITORS
#10476BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#10477Pyrazine-containing compound
#10478CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
#10479TREATMENT OF SYSTOLIC DYSFUNCTION AND HEART FAILURE WITH REDUCED EJECTION FRACTION WITH THE COMPOUND (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE
#10480TREATMENT OF UROTHELIAL AND KIDNEY CANCERS BY USE OF ENDOTHELIN B RECEPTOR ANTAGONISTS
#10481BET INHIBITORS AS A TREATMENT FOR MYELOFIBROSIS
#10482REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS
#10483TREATMENT COMPRISING FXR AGONISTS
#10484Autotaxin inhibitor compounds
#10485Treatment of mitochondrial diseases
#10486COMBINATION OF A CHROMENE COMPOUND AND A SECOND ACTIVE AGENT
#10487USE OF BIPOLAR TRANS CAROTENOIDS WITH CHEMOTHERAPY AND RADIOTHERAPY FOR TREATMENT OF CANCER
#10488DIBENZYLAMINES AS AMINO ACID TRANSPORT INHIBITORS
#10489Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
#10490Combination Therapies for Managing Cancer
#10491METHODS OF USING CANNABIDIOL AND A STEROID
#10492PROCESS FOR PREPARING PRESSURE SENSITIVE ADHESIVE COMPOUNDS FOR USE IN A TRANSDERMAL THERAPEUTIC SYSTEM
#10493FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#10494Absorbent structure for absorbent articles
#10495COMPOSITIONS COMPRISING AMINO ACIDS AND A FURTHER COMPONENT FOR THE SUPPLY OF AMINO ACIDS TO A MONOGASTRIC ANIMAL SUCH AS A HUMAN OR A PIG
#10496METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#10497METHODS FOR IDENTIFYING AND TREATING HIGH-PLASTICITY CELL STATE DRIVING TUMOR PROGRESSION IN LUNG CANCER
#10498COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#10499INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#10500Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)